Fig. 2
From: Myriad and the mass media: the covering of a gene patent controversy
Overall tenor of newspaper articles on Myriad Genetic's BRCA1/2 patents.
Fig. 2 | Genetics in Medicine
From: Myriad and the mass media: the covering of a gene patent controversy
Overall tenor of newspaper articles on Myriad Genetic's BRCA1/2 patents.
